In an editorial.
In an editorial, Setsuko K. Chambers, of the Arizona Cancer Center in Tucson, describes the strengths and weaknesses this prospective study of lymphadenectomy should be regarded as definitive this pivotal study, and the results to dictate the clinical treatment for advanced ovarian cancer. She writes. as disappointing as the result may be to some gynecologic oncologists, the body of evidence maximum without systematic lymphadenectomy as part of front-line surgical debulking in the management of advanced ovarian cancer favor .
Thera Logics expects to participate in a non-profit foundation as a potential source of research revenue. Be speakers Max Wallace, the former C. Thera Logics and Trimeris Pharmaceuticals and Sankar Ghosh, Professor of Immunobiology and Molecular Biophysics and Biochemistry at Yale University and co-founder of Thera Logics – .
Ovarian cancer is the fifth most common cancer. In the United States, about 25,000 women were in 2004, in 2004, and 16,000 women died. The long-term survival after after surgery and chemotherapy, but only about 30 percent of patients with advanced ovarian cancer survive 5 or more years after diagnosis. The removal of the aortic and pelvic lymph nodes during cytoreductive surgery the tumor the tumor – Retrospective studies have shown that suggested lymphadenectomy survival survival, but the value of the procedure remains controversial.
Wallace and Ghosh will discuss how they have managed to move quickly from basic research to practical application of a technology, although Thera Logics has yet to be seen on the web or with a physical research facility.That means food supplements do not need approval from the FDA marketing marketed -. Except in case a new nutrition ingredient, when pre-market review for security data and different info is a legal requirement, Is currently not FDA with the it refers to the safety or effectiveness in front or by underpinning markets of offers its products.. On the FDA’s on that role in regulating food supplements compared to responsibility of the manufacturer of the market.
In October 1994, the Dietary Supplement Healthcare and Education Act (DSHEA into into law by President Clinton.
The manufacturers will not need to themselves nor their supplements items Up to with FDA until producing or selling them. There are currently no FDA requirements made specifically for dietary supplements the build up minimum standards of the practices for producing of nutritional supplements.